LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories SA (ABL) announced today that it has signed a Patent Immunity Agreement and has dismissed all claims against Stanford University, thus resolving any disputes related to ABL US patents 6.081.786, 6.188.988 and their foreign equivalents, ensuring the free access for all uses to Stanford and all the Stanford researchers and related parties. In exchange, ABL obtained free access to Stanford’s US Patents RE38352, 5.856.086 and 5.631.128 and their foreign equivalents.
